vTv Therapeutics (VTVT) Misses Q2 EPS by 92c
Tweet
Share
E-mailGet Alerts VTVT Hot Sheet
Join SI Premium – FREE
vTv Therapeutics (NASDAQ: VTVT) reported Q2 EPS of ($0.92).
For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Keefe, Bruyette & Woods Downgrades Bain Capital Specialty Finance (BCSF) to Market Perform
- Keefe, Bruyette & Woods Upgrades Nayax (NYAX) to Outperform
- Defence Therapeutics names Ryan Simms as COO and radiopharmaceutical head
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
